VLTriz-2 (Tirzepatide) is a research peptide under study for its potential role in incretin-related receptor signaling and metabolic pathway models. Preclinical research typically focuses on appetite signaling, glucose regulation markers, and energy-balance endpoints, often exploring the involvement of multiple receptors. It is intended solely for laboratory research and should not be used for human or animal consumption.
Lab reports on file:
Lab report · Jul 6, 2026

Fast pricing. No commitment. Instant response.